A PYMNTS Company

US: DOJ may not challenge Aetna-CVS deal

By  |  July 15, 2018

Shares of CVS Health Corp and Aetna Inc jumped Thursday, July 12, on reports that the US Department of Justice (DOJ) will not challenge the US$69 billion purchase of the Hartford health insurer.

Bloomberg reported the DOJ’s decision, citing publication Reorg Research.

Shares of Aetna closed at $191.08, up less than 2%, after climbing nearly 2.5% earlier in the day. CVS ended the day at US$67.99, up 1% after jumping more than 4% at one point during the day.

The federal government blocked Aetna last year from buying Humana in Louisville, in a US$37 billion deal. The DOJ said the acquisition was anti-consumer and a federal judge agreed, striking down the deal.

Full Content: Bloomberg

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.